RAINSFORD, Kim (2011). Fifty years since the discovery of ibuprofen. Inflammopharmacology, 19 (6), 293-297.Full text not available from this repository.
It is now 50 years since the discovery of the pharmacological effects of the non-steroidal anti-inflammatory drug (NSAID) ibuprofen, and over 40 years since its introduction to clinical use as a prescription drug for the treatment of arthritic pain and inflammation (Adams 1987; Rainsford 1999, 2003). The initial discovery of the anti-inflammatory effects of ibuprofen in guinea pigs was made on 19 December 1961 by Dr. (now Professor) Stewart Adams, OBE (Fig. 1), the late Dr. John Nicholson (who was the chemist who synthesized the drug), and Mr. Colin Burrows at the Boots Co., Nottingham, UK (Rainsford 1999). The development of ibuprofen by the Boots Company, UK, was based on the need to have a safer form of aspirin (a “Super Aspirin”) without its gastro-intestinal effects, and also without the serious adverse effects of phenylbutazone and corticosteroids; these drugs being the principal anti-inflammatory agents available at the time (Adams 1987; Rainsford 1999).
|Research Institute, Centre or Group:||Biomolecular Sciences Research Centre|
|Depositing User:||Louise Vickers|
|Date Deposited:||31 Oct 2014 11:25|
|Last Modified:||31 Oct 2014 11:26|
Actions (login required)
Downloads per month over past year